10 results
AACE/ACE 2018 Glycemic Control Algorithm

#AACE #2018 #Glycemic #Diabetes #DM2 #Control #Medication #Algorithm #Endocrinology #PrimaryCare #Management
AACE/ACE 2018 Glycemic ... #AACE #2018 #Glycemic ... #Diabetes #DM2 ... Endocrinology #PrimaryCare
Summary and links to five landmark trials of intensive control vs standard therapy in DM2:

 UKPDS
Summary and links ... standard therapy in DM2 ... Endocrinology #PrimaryCare ... #Diabetes #DM2
Metformin Pharmacology Summary
Mechanisms of Action:
 • Suppresses gluconeogenesis by the liver
 • Increases insulin-mediated glucose utilization
Metformin Pharmacology Summary ... agent • Does not cause ... mL/minute/1.73 m2 ... #Pharmacology #Summary ... #DM2 #diabetes
Type 2 Diabetes - Screening, Diagnosis and Management Algorithm
Lifestyle  Modifications (Diet and Exercise) -> Start
relative with DM2 ... Hypertension, Overweight, Abdominal ... • Secondary Causes ... Management #algorithm #DM2 ... Classification #primarycare
Management of type 2 diabetes in adults: summary of updated NICE guidance #Management #IM #PrimaryCare #Endo
Management of type 2 diabetes ... in adults: summary ... Management #IM #PrimaryCare ... #Endo #DM2 #BMJ
SGLT2 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits SGLT2 (sodium/glucose cotransporter 2) in the proximal tubule,
- Pharmacology Summary ... mL/minute/1.73 m2 ... diabetic ketoacidosis ... #Pharmacology #Summary ... #DM2 #diabetes
DPP-4 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits DPP-4 (dipeptidyl peptidase 4), which normally inactivates GLP-1
- Pharmacology Summary ... not definitively cause ... #Pharmacology #Summary ... #DM2 #diabetes
GLP-1 Receptor Agonists - Pharmacology Summary
Mechanisms of Action: Stimulate glucose-dependent insulin release from the pancreas (GLP-1
- Pharmacology Summary ... e.g. diarrhea, nausea ... not definitively cause ... #Pharmacology #Summary ... #DM2 #diabetes
Acromegaly - Diagnosis and Management Summary - GrepMed Handbook 

Clinical Presentation: 
 • Classic Acromegaly: frontal
and Management Summary ... Insulin resist + DM ... peripheral (bronchial/abdominal ... Pegvisomant) ± D2 ... or refractory cases
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
Insulin dependent DM ... Intraabdominal - Orthopedic ... Diabetes regimen ... undergoing AAA or upper abdominal